A new biotechnology company in McKinney has ambitions to become the world's first fully integrated platform for polymerase chain reaction (PCR) testing - the same technology behind a common COVID-19 ...

Over the past four years, many of us have become accustomed to a swab up the nose to test for COVID-19, using at-home rapid antigen tests or the more accurate clinic-provided PCR tests with a longer ...

Many people will have experienced being unwell with an unknown infection and having to undergo multiple tests to determine the culprit. This sequential process of elimination can be time-consuming and ...

Automated quality control using rapid PCR assays is replacing 28-day culture tests, cutting biopharmaceutical lot release ...

Researchers often call the polymerase chain reaction test – known as the PCR test – "the gold standard" for detecting the COVID-19 virus. The test is considered highly reliable and effective, and it ...

Molecular testing, or molecular diagnostics, refers to a group of tests that look at the genetic material in a specimen. It can detect genetic risk factors for certain diseases or provide evidence of ...

PCR is a mainstay in diagnostics, but whether a sample is collected at a clinic or at home, such tests require sending a sample to a lab and then waiting for results. A new FDA authorized ...

You’ve been exposed to COVID and are starting to get symptoms. But after a couple of days of testing with rapid antigen tests (RATs), your tests remain negative. Mass PCR testing has been scaled back, ...